Revolution Medicines (RVMD) Current Assets (2019 - 2026)
Revolution Medicines (RVMD) recorded Current Assets of $4.03 billion in Q2 2026, up 85.1% from $2.18 billion a year earlier and up 104.7% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Revolution Medicines reported Current Assets of $2.08 billion, down 10.9% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of 35.5% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $2.33 billion in FY2024 (+23.9%), $1.88 billion in FY2023 (+184.7%), $660.19 million in FY2022 (+11.9%) and $589.77 million in FY2021 (+29.9%).
- The Q2 2026 figure is the highest quarterly Current Assets in data going back to Q4 2019.
- On a year-over-year basis, Current Assets rose in six of the last eight quarters, with growth averaging 33.1%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 184.7% in Q4 2023, against a decline of 26.9% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.97 billion (Q1 2026), $2.08 billion (Q4 2025) and $1.98 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 4.03 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.03 Bn |
| Mar 31, 2026 | 1.97 Bn |
| Dec 31, 2025 | 2.08 Bn |
| Sep 30, 2025 | 1.98 Bn |
| Jun 30, 2025 | 2.18 Bn |
| Mar 31, 2025 | 2.13 Bn |
| Dec 31, 2024 | 2.33 Bn |
| Sep 30, 2024 | 1.58 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.73 Bn |
| Dec 31, 2023 | 1.88 Bn |
| Sep 30, 2023 | 824.47 Mn |
| Jun 30, 2023 | 922.09 Mn |
| Mar 31, 2023 | 922.75 Mn |
| Dec 31, 2022 | 660.19 Mn |
| Sep 30, 2022 | 675.11 Mn |
| Jun 30, 2022 | 483.05 Mn |
| Mar 31, 2022 | 534.34 Mn |
| Dec 31, 2021 | 589.77 Mn |
| Sep 30, 2021 | 623.54 Mn |
API Access
Revolution Medicines Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();